ID | 62226 |
JaLCDOI | |
フルテキストURL | |
著者 |
Wada, Riho
Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fujiwara, Masaki
Department of Neuropsychiatry, Okayama University Hospital
Yamada, Yuto
Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Nakaya, Naoki
Department of Health Sciences, Saitama Prefectural University
Fujimori, Maiko
Division of Health Care Research, Behavioral Sciences and Survivorship Research Group, National Cancer Center
So, Ryuhei
Okayama Psychiatric Medical Center
Kodama, Masafumi
Okayama Psychiatric Medical Center
Higuchi, Yuji
Care of Your Mind, Taiyo Hills Hospital
Kakeda, Kyoko
Department of Neuropsychiatry, Kochi Medical School, Kochi University
Uchitomi, Yosuke
Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital
Yamada, Norihito
Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Inagaki, Masatoshi
Department of Psychiatry, Faculty of Medicine, Shimane University
|
抄録 | It is necessary to assess functional impairment when treating schizophrenia. The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) has been adopted as a measure of functional disability in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This study was a secondary analysis from a cross-sectional study of health-related behaviors among patients with schizophrenia. We examined the validity and reliability of the Japanese version of the 12-item WHODAS 2.0 when self-administered by such patients. Participants were 350 outpatients with schizophrenia from a psychiatric hospital. The standard six-factor structure of the WHODAS 2.0 showed a good fit for these participants. The Cronbach’s alpha coefficient was 0.858, showing good internal consistency. The WHODAS 2.0 showed moderate correlations with the modified Global Assessment of Functioning and Kessler 6 scales (r=−0.434 and 0.555, respectively). The results of this study show that the Japanese version of the 12-item self-administered WHODAS 2.0 has good internal consistency and convergent validity among patients with schizophrenia. Further exploration of the usefulness of WHODAS 2.0 in clinical settings is needed.
|
キーワード | disability
schizophrenia
validity
reliability
WHODAS 2.0
|
Amo Type | Original Article
|
出版物タイトル |
Acta Medica Okayama
|
発行日 | 2021-06
|
巻 | 75巻
|
号 | 3号
|
出版者 | Okayama University Medical School
|
開始ページ | 315
|
終了ページ | 322
|
ISSN | 0386-300X
|
NCID | AA00508441
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
著作権者 | CopyrightⒸ 2021 by Okayama University Medical School
|
論文のバージョン | publisher
|
査読 |
有り
|
PubMed ID | |
NAID |